Pluri Inc. — Director's Dealing 2015

Sep 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2015-09-21

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-21	Common Stock	P	11500	$2.12	Acquired	36500	Indirect
2015-09-21	Common Stock	P	14000	$2.10	Acquired	50500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1968298	Direct